OTCMKTS:BGMD BG Medicine (BGMD) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart About BG Medicine Stock (OTCMKTS:BGMD) Get BG Medicine alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BG Medicine, Inc., headquartered in Waltham, Massachusetts, is a clinical diagnostics company specializing in proprietary biomarker assays for the diagnosis and management of cardiovascular and renal diseases. The company’s flagship product is a B-type natriuretic peptide (BNP) test, offered both as a laboratory-developed test in its CLIA-certified facility and as reagent kits compatible with major immunoassay analyzers. This test aids clinicians in assessing heart failure severity and guiding patient treatment decisions. Founded in the early 2000s, BG Medicine has established partnerships with hospital and reference laboratories across North America and select international markets. Beyond its BNP assay, the company has invested in the development of additional peptide-based immunoassays, working toward a multi-marker approach for more comprehensive cardiovascular risk evaluation and disease management. Led by a management team with deep experience in diagnostic development and commercialization, BG Medicine continues to focus its research and development efforts on expanding its test portfolio. By collaborating with instrument manufacturers and clinical laboratories, the company aims to deliver precision diagnostic tools that support personalized care strategies for patients with chronic heart and kidney conditions.AI Generated. May Contain Errors. Read More Receive BGMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BG Medicine and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BGMD Stock News HeadlinesBGMD Share News TodayJuly 6, 2026 | uk.investing.comBG Medicine, Inc. (BGMD)January 12, 2025 | finance.yahoo.comA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One executive order could change that — potentially triggering the largest wealth transfer into gold in modern American history. The last time the U.S. faced this combination of inflation, debt, and monetary pressure, gold climbed 2,300% in the 1970s. Reagan Gold Group's free 2026 Gold Guide breaks down what investors need to know now. | Reagan Gold Group (Ad)Bowling Green’s UK College of Medicine satellite campus names new associate deanAugust 21, 2024 | msn.comModernizing MedicineApril 6, 2024 | forbes.comMedicine Through TimeJuly 22, 2023 | bbc.co.ukBGMD - BG Medicine, Inc.June 7, 2023 | finance.yahoo.comJiangsu Hengrui MedicineApril 22, 2023 | forbes.comSee More Headlines BGMD Stock Analysis - Frequently Asked Questions How were BG Medicine's earnings last quarter? BG Medicine Inc. (OTCMKTS:BGMD) issued its quarterly earnings data on Tuesday, November, 17th. The medical research company reported ($0.27) earnings per share for the quarter. The medical research company earned $334 million during the quarter, compared to the consensus estimate of $695 million. How do I buy shares of BG Medicine? Shares of BGMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BG Medicine own? Based on aggregate information from My MarketBeat watchlists, some other companies that BG Medicine investors own include Blue Ridge Mountain Resources (MHRCQ), Athersys (ATHX), Bristol Myers Squibb (BMY) and Catalyst Pharmaceuticals (CPRX). Company Calendar Last Earnings11/17/2015Today9/11/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolOTCMKTS:BGMD Previous SymbolNASDAQ:BGMD CIK1407038 Webwww.bg-medicine.com Phone(508) 549-5710Fax781-895-1119Employees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta1.02 The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (OTCMKTS:BGMD) was last updated on 9/12/2026 by MarketBeat.com Staff. From Our PartnersThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredElon Musk to Trigger Next AI Wave on November 11th?Jeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredShocking AI prediction from the “Billionaire Whisperer"Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | SponsoredBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredThis metric called 1929, 1969 and 2000 [it's screaming now]The Buffett Indicator once flagged the 1929, 1969, and 2000 market peaks - and it's now at 231%, its highest r...Golden Portfolio | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredThe retirement income that answers “yes” when everything else says noTodd Phillips has spent 30 years studying safe-money income. He says most so-called income sources fail one te...Eagle Publishing | SponsoredElon’s “nude” scandal – a big opportunity?Louis Navellier, the quantitative analyst who called Nvidia before its 44,000% run, says Elon Musk's AI ambiti...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BG Medicine Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BG Medicine With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
